Antibody Production Market Size, Share, Trends, Growth Outlook

The Global Antibody Production Market Size is estimated to register 13.1% growth over the forecast period from 2023 to 2030.

 

Antibody Production Market overview

The demand for therapeutic antibodies to treat various diseases, including cancer, autoimmune disorders, and infectious diseases, has emerged as a significant driver in the antibody production market. Advances in biomanufacturing technologies and processes, spanning cell line development, upstream and downstream processing, as well as production scale-up, contribute to increased efficiency and yield in antibody production. The trend toward personalized medicine and targeted therapies has further propelled the development of antibodies tailored to specific patient populations or disease subtypes. Additionally, the integration of artificial intelligence (AI) and automation in antibody production processes is a growing trend, enhancing the overall efficiency and precision of manufacturing workflows.

 

 

Market dynamics

Market Trend: The rising demand for therapeutic antibodies, crucial for addressing a range of diseases, is a primary driver propelling the antibody production market.

 

Market Opportunity: The convergence of artificial intelligence (AI) and automation within antibody production processes is emblematic of a transformative trend driving significant changes.

The integration of artificial intelligence (AI) and automation into antibody production processes stands as a transformative trend, driving the antibody production market towards heightened efficiency, precision, and innovation. Artificial intelligence, with its ability to process vast datasets and extract meaningful insights, plays a pivotal role in the optimization of bioprocessing parameters. AI and automation synergize to drive the antibody production market by enhancing overall operational efficiency. As these technologies become increasingly sophisticated and widely adopted, they propel the industry towards a future characterized by innovation, efficiency, and responsiveness to the evolving landscape of therapeutic antibody demand.

 

Market share analysis: The majority share belongs to Monoclonal antibodies (mAbs) in the antibody production market, surpassing both Polyclonal antibodies and Monoclonal antibodies.

Monoclonal antibodies (mAbs) hold the largest market share in antibody production, constituting 60% across Polyclonal antibodies and Monoclonal antibodies. mAbs are produced by identical immune cells, resulting in a highly specific response to a single antigen. This specificity makes them ideal for targeted therapies, diagnostic applications, and research purposes. mAbs can be consistently produced in large quantities, ensuring a reliable and reproducible supply for various applications. This consistency is crucial for maintaining therapeutic efficacy and regulatory compliance. Technological advancements have enabled the engineering of mAbs with enhanced properties, such as increased stability, improved affinity, and reduced immunogenicity.

 

Pharmaceutical and biotechnology firms take the lead in antibody production, possessing the largest market share.

Pharmaceutical and biotechnology companies hold the largest market share in antibody production, accounting for 55% across Pharmaceutical and biotechnology companies, Research laboratories, CROs, and CDMOs. These companies are the primary drivers of antibody production, emphasizing their focus on developing and commercializing therapeutic antibodies for various diseases. Investing heavily in research and development, pharmaceutical and biotechnology companies aim to identify and develop novel antibody-based therapies, thereby expanding the market for antibody production.

 

Antibody Production Market Segmentation

 By Type

• Polyclonal antibody
• Monoclonal antibody

By Process

• Upstream Processing (Bioreactors, Consumables)
• Downstream Processing (Chromatography Systems, Chromatography Resins)
• Filtration (Filtration Systems, Filtration Consumables)

By End-User

• Pharmaceutical and biotechnology companies
• Research laboratories
• CROs and CDMOs

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

   Antibody Production Market companies

• Thermo Fisher Scientific Inc (United States)
• GE Healthcare (United States)
• Sartorius AG (Germany)
• Merck KGaA (Germany)
• Pall Corporation (United States)
• Sigma-Aldrich Corporation (Germany)
• FiberCell Systems Inc (United States)
• Eppendorf AG (Germany)
• Cellab GmbH (Germany)
• INTEGRA Biosciences AG (Switzerland)

 

*List not exhaustive

Antibody Production Market Outlook 2023

1 Market Overview

1.1 Introduction to the Antibody Production Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Antibody Production Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Antibody Production Market Companies with Area Served

4.2.2 Products Offerings Global Antibody Production Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

 

6 Global Antibody Production Market Trends

6.1 Global Antibody Production Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Antibody Production Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Antibody Production Revenue (USD Million) and CAGR (%) by regions (2018-2030)

 

7 Global Antibody Production Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Antibody Production Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Antibody Production Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Antibody Production Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Antibody Production Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Antibody Production Development Regional Status and Outlook

8.1 Global Antibody Production Revenue (USD Million) By Regions (2018-2022)

8.2 North America Antibody Production Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Antibody Production Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Antibody Production Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Antibody Production Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Antibody Production Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Antibody Production Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Antibody Production Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Antibody Production Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Antibody Production Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Antibody Production Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Antibody Production Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Antibody Production Revenue (USD Million) by Applications (2018-2022)

8.5 South America Antibody Production Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Antibody Production Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Antibody Production Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Antibody Production Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Antibody Production Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Antibody Production Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Antibody Production Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Antibody Production Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Antibody Production Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Antibody Production Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Antibody Production Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Antibody Production Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Antibody Production Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Antibody Production Development Regional Status and Outlook Forecast

11.1 Global Antibody Production Revenue (USD Million) By Regions (2023-2030)

11.2 North America Antibody Production Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Antibody Production Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Antibody Production Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Antibody Production Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Antibody Production Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Antibody Production Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Antibody Production Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Antibody Production Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Antibody Production Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Antibody Production Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Antibody Production Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Antibody Production Revenue (USD Million), by Applications (2023-2030)

11.5 South America Antibody Production Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Antibody Production Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Antibody Production Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Antibody Production Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Antibody Production Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Antibody Production Revenue (USD Million), by region (2023-2030)

11.6.2 Middle East and Africa Antibody Production Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Antibody Production Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Antibody Production Market Companies with Areas Served

Table 3 Products Offerings Global Antibody Production Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Antibody Production Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Antibody Production Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Antibody Production Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Antibody Production Revenue (USD Million) By Type (2018-2022)

Table 11 Global Antibody Production Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Antibody Production Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Antibody Production Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Antibody Production Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Antibody Production Market Share (%) By Regions (2018-2022)

Table 16 North America Antibody Production Revenue (USD Million) By Country (2018-2022)

Table 17 North America Antibody Production Revenue (USD Million) By Type (2018-2022)

Table 18 North America Antibody Production Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Antibody Production Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Antibody Production Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Antibody Production Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Antibody Production Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Antibody Production Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Antibody Production Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Antibody Production Revenue (USD Million) By Country (2018-2022)

Table 26 South America Antibody Production Revenue (USD Million) By Type (2018-2022)

Table 27 South America Antibody Production Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Antibody Production Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Antibody Production Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Antibody Production Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Antibody Production Revenue (USD Million) By Type (2023-2030)

Table 33 Global Antibody Production Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Antibody Production Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Antibody Production Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Antibody Production Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Antibody Production Revenue (USD)By Country (2023-2030)

Table 38 North America Antibody Production Revenue (USD Million) By Type (2023-2030)

Table 39 North America Antibody Production Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Antibody Production Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Antibody Production Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Antibody Production Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Antibody Production Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Antibody Production Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Antibody Production Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Antibody Production Revenue (USD Million) By Country (2023-2030)

Table 47 South America Antibody Production Revenue (USD Million) By Type (2023-2030)

Table 48 South America Antibody Production Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Antibody Production Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Antibody Production Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Antibody Production Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Antibody Production Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Antibody Production Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Antibody Production Revenue Market Share (%) By Type (2022)

Figure 5 Global Antibody Production Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Antibody Production Revenue Market Share (%) By Applications (2022)

Figure 7 Global Antibody Production Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Antibody Production Market Share (%) By Regions (2022)

Figure 9 North America Antibody Production Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Antibody Production Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Antibody Production Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Antibody Production Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Antibody Production Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Antibody Production Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Antibody Production Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Antibody Production Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Antibody Production Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Antibody Production Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Antibody Production Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Antibody Production Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Antibody Production Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Antibody Production Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Antibody Production Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Antibody Production Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Antibody Production Revenue Market Share (%) By Type (2030)

Figure 26 Global Antibody Production Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Antibody Production Revenue Market Share (%) By Applications (2030)

Figure 28 Global Antibody Production Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Antibody Production Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Antibody Production Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Antibody Production Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Antibody Production Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Antibody Production Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Antibody Production Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Antibody Production Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Antibody Production Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Antibody Production Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Antibody Production Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Antibody Production Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Antibody Production Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Antibody Production Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Antibody Production Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Antibody Production Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Antibody Production Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

 

 

Antibody Production Market Segmentation

 By Type

• Polyclonal antibody
• Monoclonal antibody

By Process

• Upstream Processing (Bioreactors, Consumables)
• Downstream Processing (Chromatography Systems, Chromatography Resins)
• Filtration (Filtration Systems, Filtration Consumables)

By End-User

• Pharmaceutical and biotechnology companies
• Research laboratories
• CROs and CDMOs

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)